Literature DB >> 27645894

MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3.

Xuhui Gao1, Xuelian Wang2, Kaican Cai3, Wujun Wang3, Qun Ju3, Xiyao Yang3, Haofei Wang3, Hua Wu4.   

Abstract

In this study, we investigated the expression patterns and functional roles of microRNA 127 (miR-127) and its target gene Formin-Like 3 (FMNL3) in human esophageal squamous cell carcinoma (ESCC). Quantitative RT-PCR (qRT-PCR) was used to compare miR-127 expression between ESCC cell lines and normal esophageal epithelium cell line, as well as paired ESCC tumors and adjacent normal esophageal tissues in 33 patients. We found miR-127 was aberrantly downregulated in both ESCC cell lines and human ESCC tumors. In ESCC cell lines TE-1 and ECA109 cells, lentiviral-induced miR-127 upregulation markedly inhibited cancer proliferation and migration in vitro, and tumorigenicity in vivo. Through dual-luciferase assay and qRT-PCR, FMNL3 was confirmed to be the downstream target gene of miR-127 in ESCC. Finally, FMNL3 was downregulated by siRNA in TE-1 and ECA109 cells. And we discovered that SiRNA-induced FMNL3 downregulation had tumor suppressive effect in ESCC, inhibiting cancer proliferation, migration in vitro, and tumorigenicity in vivo. These results suggest that miR-127 is downregulated and acting as tumor suppressor in ESCC. Inversely, FMNL3, the target gene of miR-127, is upregulated and acting as an oncogene in ESCC.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer in vitro growth; Cancer in vivo growth, FMNL3; Esophageal squamous cell carcinoma; MiR-127

Mesh:

Substances:

Year:  2016        PMID: 27645894     DOI: 10.1016/j.ejphar.2016.09.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells.

Authors:  Maxine Umeh-Garcia; Catalina Simion; Pui-Yan Ho; Neelu Batra; Anastasia L Berg; Kermit L Carraway; Aiming Yu; Colleen Sweeney
Journal:  Cancer Res       Date:  2019-11-06       Impact factor: 12.701

2.  MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein.

Authors:  Suna Zhou; Yaoyou Cui; Dequan Yu; Jun Liang; Mingxin Zhang; Wenguang Ye
Journal:  Onco Targets Ther       Date:  2017-05-11       Impact factor: 4.147

3.  MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiation.

Authors:  Laura Crisafulli; Sharon Muggeo; Paolo Uva; Yulei Wang; Masayuki Iwasaki; Silvia Locatelli; Achille Anselmo; Federico S Colombo; Carmelo Carlo-Stella; Michael L Cleary; Anna Villa; Bernhard Gentner; Francesca Ficara
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

4.  MicroRNA-127 Inhibits the Progression of Melanoma by Downregulating Delta-Like Homologue 1.

Authors:  Ping Tian; Ling Tao; Yujun Wang; Xiaobing Han
Journal:  Biomed Res Int       Date:  2020-01-18       Impact factor: 3.411

5.  Tumor Suppressor Function of miR-127-3p and miR-376a-3p in Osteosarcoma Cells.

Authors:  Joerg Fellenberg; Burkhard Lehner; Heiner Saehr; Astrid Schenker; Pierre Kunz
Journal:  Cancers (Basel)       Date:  2019-12-14       Impact factor: 6.639

6.  Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC).

Authors:  Jian Wang; Pengyi Yu; Judong Luo; Zhiqiang Sun; Jingping Yu; Jianlin Wang
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

7.  MicroRNA Profile for Diagnostic and Prognostic Biomarkers in Thyroid Cancer.

Authors:  Jong-Lyul Park; Seon-Kyu Kim; Sora Jeon; Chan-Kwon Jung; Yong-Sung Kim
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

8.  The mechanism study of miR-125b in occurrence and progression of multiple myeloma.

Authors:  Da Gao; Zhen Xiao; Hui-Ping Li; Dong-Hai Han; Ya-Peng Zhang
Journal:  Cancer Med       Date:  2017-12-07       Impact factor: 4.452

9.  miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.

Authors:  Baoping Lang; Song Zhao
Journal:  Oncol Rep       Date:  2017-11-01       Impact factor: 3.906

10.  Formin-like 3 regulates RhoC/FAK pathway and actin assembly to promote cell invasion in colorectal carcinoma.

Authors:  Yuan-Feng Zeng; Yi-Sheng Xiao; Yong Liu; Xiao-Jiang Luo; Li-Dan Wen; Qian Liu; Min Chen
Journal:  World J Gastroenterol       Date:  2018-09-14       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.